INmune Bio, Inc. Announces Third Quarter 2021 Results and Provides Business Update

NEXT STORY
23andMe Provides Updated Timing for FY2022 Second Quarter Financial Results and Announces New Online Q&A Platform for Shareholders
PREV STORY
Oyster Point Pharma’s TYRVAYA™ (varenicline solution) Nasal Spray is Now Available at U.S. Regional Wholesalers for Distribution to Pharmacies for the Treatment of the Signs and Symptoms of Dry Eye Disease
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BK Ultrasound, Powered by Analogic, Showcases bkFusion at AUA 2017

PEABODY, Mass., May 11, 2017 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG), enabling the world's ...

author_avatar
NASDAQ Market News

Cue Biopharma Announces First Patient Dosed in Part B Patient Expansion of CUE-101 Phase 1 Monotherapy Trial in HPV+ Second Line and Beyond HNSCC

author_avatar
NASDAQ Market News

Cooper University Health Care First Hospital Site in the Nation to Host Training Program for Elite U.S. Army Resuscitation Forward Surgical Team

author_avatar
NASDAQ Market News